FDA Inspection
C. B. Fleet Company, Inc.C. B. Fleet Company, Inc. – FDA Inspection, Dec 1, 2023
Record Details
This FDA Inspection record concerns C. B. Fleet Company, Inc., with an inspection on December 1, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · a7beb1f5-52aa-4e01-8ba0-12bd8d75de43
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1224305
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
3- 21 CFR 211.192Investigations of discrepancies, failures
- 21 CFR 211.63Equipment Design, Size and Location
- 21 CFR 211.67(b)Written procedures not established/followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of C. B. Fleet Company, Inc.
9| Date | Classification | Office | Project area |
|---|---|---|---|
| September 24, 2026 | Not classified | Baltimore District Office | |
| April 18, 2025 | OAI | Baltimore District Office | Drug Quality Assurance |
| June 14, 2024 | VAI | Center for Food Safety and Applied Nutrition | Colors and Cosmetics Technology |
| August 22, 2019 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| December 1, 2017 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for C. B. Fleet Company, Inc.
- FDA Inspection 1299266 - 2026-09-24
- FDA Inspection 1265795 - 2025-04-18
- FDA Inspection 1240349 - 2024-06-14
- FDA Inspection 1102099 - 2019-08-22
- FDA Inspection 1039393 - 2017-12-01
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.